Get the Stockscreener App
83.87
1.80%
1.48
Pre-market:
84.26
0.39
+0.47%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $83.87, with a volume of 7.19M.
It is up +1.80% in the last 24 hours and up +4.51% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$82.39
Open:
$82.83
24h Volume:
7.19M
Relative Volume:
0.72
Market Cap:
$107.36B
Revenue:
$36.36B
Net Income/Loss:
$4.84B
P/E Ratio:
22.54
EPS:
3.7212
Net Cash Flow:
$5.43B
1W Performance:
+0.82%
1M Performance:
+4.51%
6M Performance:
-14.01%
1Y Performance:
-6.19%
1-Day Range:
$82.56
$84.19
1-Week Range:
$81.10
$85.99
52-Week Range:
$73.31
$106.33
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Resumed | Barclays | Overweight |
| Feb-09-26 | Upgrade | Needham | Hold → Buy |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Jan-30-26 | Resumed | Wells Fargo | Overweight |
| Jan-06-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-19-25 | Upgrade | Goldman | Sell → Neutral |
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Medtronic PLC (XSWX:MDT) Stock Price, Trades & News - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Medtronic PLC stock outperforms competitors on strong trading day - MarketWatch
Medtronic (MDT) Shares Surge on Reimbursement Hopes for Renal De - GuruFocus
MDT stock holds steady as medical technology demand supports long term growth - ad-hoc-news.de
Medtronic gains on coverage hopes for renal denervation (MDT) - Seeking Alpha
Medtronic (MDT) Receives Positive News from AMA CPT Panel on Ren - GuruFocus
TD Cowen cuts Medtronic stock price target on TAVR headwinds By Investing.com - Investing.com Nigeria
Medtronic: Undervalued, And The Tailwinds Are Just Getting Started (NYSE:MDT) - Seeking Alpha
Explosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGR - GlobeNewswire Inc.
Medtronic: Guidance Built To Be BeatenBuy - Seeking Alpha
TD Cowen Adjusts Price Target on Medtronic to $100 From $119 - marketscreener.com
Medtronic (MDT) Could Be 9% Undervalued On Recall News - Yahoo Finance
Regeneron Cites Medtronic Ruling In Amgen Bundling Case - Law360
Insider Sell: Matthew Walter Sells Shares of Medtronic PLC - GuruFocus
Global Orthopedic Surgical Robots Market Report Published — Profiles Stryker, Zimmer Biomet, DePuy Synthes, and Medtronic - Yahoo Finance UK
Medtronic: A Near Decade High Dividend For This Aristocrat (NYSE:MDT) - Seeking Alpha
Medtronic plc highlights global medtech reach as a leading implantable device maker - Ad-hoc-news.de
Medtronic (MDT) Following Octopus 4 Recall Has An Undervalued Narrative Under Review - simplywall.st
Medtronic PLC stock underperforms Wednesday when compared to competitors - MarketWatch
Form 144 Medtronic plc For: 8 July By Investing.com - Investing.com Nigeria
Proposed sale of Medtronic (NYSE: MDT) common shares via Form 144 notice - Stock Titan
Medtronic (MDT) Q4 2025 earnings summary - Quartr
Medtronic stock leans on its core device business - Ad-hoc-news.de
Medtronic plc highlights diversified medical technology portfolio as global procedures recover - AD HOC NEWS
Medtronic Denied Bid To Nix $382M Antitrust Loss - Law360
Top 10 medtech deals in the first half of 2026 - MedTech Dive
Evercore ISI Adjusts Price Target on Medtronic to $105 From $106 - marketscreener.com
Medtronic plc highlights its global medical technology role as investors monitor long-term growth - AD HOC NEWS
Medtronic Plc (MDT) Stock Analysis: Healthcare Giant Offers A 17.53% Upside Potential - DirectorsTalk Interviews
How Strong Q4 Results And Retia Deal At Medtronic (MDT) Have Changed Its Investment Story - Sahm
Price to earnings forward of Medtronic Plc – MIL:1MDT - TradingView
Medtronic Notifies 3.8 Million After ShinyHunters Data Breach - Security Affairs
Enterprise value to EBITDA forward of Medtronic plc. – NYSE:MDT - TradingView
MDTMedtronic Plc Latest SEC Filings - Finviz
Why Is Medtronic (MDT) Up 1.5% Since Last Earnings Report? - Yahoo Finance
Medtronic (MDT) Alerts Cyberattack Victims While Expanding Retia Cardiac Monitoring Partnership - Yahoo Finance
Medtronic starts to notify people affected by cyberattack - MedTech Dive
MDT News | MEDTRONIC PLC (NYSE:MDT) - ChartMill
A Look at Medtronic PLC (MDT) After 5.0% Gain -- GF Value $99.55 vs Price $83.19 - GuruFocus
Medtronic plc (MDT) & Retia Expand Partnership to Target High-Risk Surgical and Critically ill Patients - Yahoo Finance
Price to sales forward of Medtronic plc. – NYSE:MDT - TradingView
Price to sales forward of Medtronic Plc – MIL:1MDT - TradingView
Medtronic plc highlights its global medical technology role as investors track long-term growth driv - AD HOC NEWS
List of 71 Acquisitions by Medtronic (Jul 2026) - Tracxn
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Is Medtronic PLC (MDT) a Bargain After 3.3% Drop? GF Value Says Undervalued - GuruFocus
Medtronic PLC stock underperforms Tuesday when compared to competitors - MarketWatch
Medtronic PLC Stock (MDT) Closed Down by 3.30% on Jun 30: Key Drivers Unveiled - TradingKey
Medtronic reports solid Q4 earnings, shares steady ahead August update - AD HOC NEWS
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):